Cargando…
Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment
BACKGROUND: Mild cognitive impairment (MCI) is a syndrome characterised by a decline in cognition but relatively intact activities of daily living. People with MCI have an increased risk of developing dementia, and MCI is often referred to as a transitional stage between healthy ageing and dementia....
Autores principales: | Steiner, Genevieve Z., Bensoussan, Alan, Liu, Jianxun, Hohenberg, Mark I., Chang, Dennis H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6156958/ https://www.ncbi.nlm.nih.gov/pubmed/30253809 http://dx.doi.org/10.1186/s13063-018-2912-0 |
Ejemplares similares
-
A randomized, double‐blind, placebo‐controlled, parallel‐group 12‐week pilot phase II trial of SaiLuoTong (SLT) for cognitive function in older adults with mild cognitive impairment
por: Steiner‐Lim, Genevieve Z., et al.
Publicado: (2023) -
The effect of Sailuotong (SLT) on neurocognitive and cardiovascular function in healthy adults: a randomised, double-blind, placebo controlled crossover pilot trial
por: Steiner, Genevieve Z., et al.
Publicado: (2016) -
Study protocol for a phase III randomised controlled trial of Sailuotong (SLT) for vascular dementia and Alzheimer’s disease with cerebrovascular disease
por: Karamacoska, Diana, et al.
Publicado: (2023) -
Endothelium-Independent Vasodilatory Effect of Sailuotong (SLT) on Rat Isolated Tail Artery
por: Yeon, S. Y., et al.
Publicado: (2020) -
Efficacy of Cognition Support Formula® on cognitive function in older adults with subjective cognitive impairment: a protocol for a 26-week, randomised, double-blind, placebo-controlled trial
por: Cave, Adele E., et al.
Publicado: (2019)